-
Metabolic Biomarkers in Thoracic Cancers
Study
phs003880
-
A Personalized Neoantigen Vaccine Generates Anti-Tumor Immunity in High-Risk Renal Cell Carcinoma
Study
phs003710
-
CD4 T Cell Subsets in Human Metastatic Melanoma
Study
phs003816
-
Distinct immune cell infiltration patterns in PDAC exhibit divergent immune cell selection and immunosuppressive mechanisms
Study
EGAS50000000726
-
Spatial Transcriptomics of Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by Surgery
Study
phs003862
-
Surgery in combination with immune checkpoint therapy as an effective treatment for patients with metastatic cancer.
Study
EGAS00001005667
-
Whole Exome Sequencing of paired gDNAs and PPGL tumor DNA from patients with cyanotic congenital heart disease
Dataset
EGAD50000001201
-
Developing Targeted Therapy for Patients with Multiple Myeloma and Gain or Amplification of Chr1q (1q+)
Study
phs003886
-
Genomics Analysis Reveals Molecular Patterns of Tumorigenesis in HPV-Associated and HPV-Independent Sinonasal Squamous Cell Carcinoma
Study
phs003591
-
A Phase I Study of the Treatment of Recurrent Malignant Glioma with CAN-3110 (AKA rQNestin34.5v.2), a Genetically Engineered HSV-1 Virus
Study
phs003378
-
Integrated Somatic and Germline Molecular Properties Dictating Biological and Clinical Phenotypes in Cancer
Study
phs003438
-
Addiction of Primary Cutaneous Gamma-Delta T-cell Lymphomas to JAK-STAT Signaling
Study
phs003837
-
Immune-Related Adverse Events after Immune Checkpoint Blockade-Based Therapy are Associated with Improved Survival in Advanced Sarcoma
Study
phs003284
-
Multi-Omic Investigation of Beckwith-Wiedemann Syndrome Hepatoblastoma
Study
phs002614
-
Next-generation molecular analysis of surgical margins in oral squamous cell carcinoma for assessment of microscopic residual disease and personalized postoperative treatment decision
Study
EGAS50000000823
-
mUM patient biopsies bulk RNAseq
Dataset
EGAD50000001225
-
Exome-sequencing on early oral squamous cell carcinoma with clear margins
Dataset
EGAD50000001209
-
RNA-seq of murine osteosarcoma cell line genetically modified for CYR61
Dataset
EGAD50000000747
-
DAC_RNA-seq of murine osteosarcoma cell line genetically modified for CYR61
Dac
EGAC50000000352
-
RNAseq samples of patients with anti-PD-1 resistant HNSCC from a non-randomized, open-label phase 1b clinical trial
Study
EGAS50000000728
-
WES samples of patients with anti-PD-1 resistant HNSCC from a non-randomized, open-label phase 1b clinical trial
Study
EGAS50000000729
-
RNA-seq of murine osteosarcoma cell line genetically modified for CYR61
Study
EGAS50000000526
-
Target sequencing for 53 synovial sarcoma patients
Study
EGAS50000000522
-
Whole exome sequencing data of patients with resectable esophageal adenocarcinoma treated with neoadjuvant atezolizumab and chemoradiation (PERFECT)
Study
EGAS00001006504
-
Whole Exome Sequencing (WES) data of PERFECT trial
Dataset
EGAD50000001153
-
"IL-17A-Producing ILC3s and Duodenal Adenoma in FAP"
Dac
EGAC00001003301
-
Genetic subtyping by Whole Exome Sequencing across Diffuse Large B Cell Lymphoma and Plasmablastic Lymphoma.
Study
EGAS50000000371
-
Immune Determinants of Resistance to PD-1 Blockade in Renal Cell Carcinoma
Study
phs003618
-
metastatic uveal melanoma tumour biopsies (n=35)
Study
EGAS50000000836
-
Aberrant RNA-splicing (neojunctions) offers a new source for targets, and our neoantigen discovery platform (SNIPP) characterizes a novel class of clonally-expressed splicing-derived neoantigens that elicit a CD8+ T-cell-mediated tumor killing response.
Study
EGAS00001007986
-
Discovery and validation of an ancillary genomic test of malignancy for primary melanocytic tumors
Study
EGAS50000000887
-
Targeted panel DNA sequencing of melanomas, nevi and melanocytic tumors
Dataset
EGAD50000001297
-
Tumor Profiler Project - OV scRNA data additional samples
Dataset
EGAD50000001293
-
Tumor Profiler Project - OV scDNA data additional samples
Dataset
EGAD50000001294
-
DNA Methylation in Prostate Tumor and Paired Benign Tissue for African and European Ancestry Men
Study
phs003516
-
Depth of Response Correlates with Improved Outcomes for Early Interception in a High-Risk Smoldering Multiple Myeloma Clinical Trial Using the Combination of Ixazomib, Lenalidomide, and Dexamethasone
Study
phs003827
-
DAC for study involving the spatial transcriptomics analysis of HPV-dependent and HPV-independent vulval squamous cell carcinoma at Imperial College London.
Dac
EGAC00001003515
-
ATAC-seq in KMS11 vs TKO cells
Study
EGAS50000000076
-
ChIP-seq in KMS11 and TKO cells
Study
EGAS50000000077
-
MicroC in KMS11 and TKO cells
Study
EGAS50000000078
-
Array-based methylation analysis of SDHB-deficient pheochromocytoma and paraganglioma
Study
EGAS00001007844
-
Gene expression adaptation of metastases to their host tissue
Study
EGAS50000000817
-
Single-cell RNA-sequencing on malignant and benign tissue samples
Dataset
EGAD50000001203
-
Mutational Profile in Newly Diagnosed Diffuse Large B-Cell Lymphoma: GAINED Study
Study
EGAS50000000929
-
MOSAIC Window Glioblastoma Data
Dataset
EGAD50000001352
-
Mutational Profile in Newly Diagnosed Diffuse Large B-Cell Lymphoma: Insights from the GAINED Study
Dac
EGAC50000000540
-
Nanopore whole-genome sequencing of human osteosarcomas
Dataset
EGAD50000000925
-
10x Single Cell Gene Expression Library SCRNA10X_CS_CHIP0187_002
Dataset
EGAD50000001372
-
Mayo Clinic Adult Diffuse Glioma Illumina OncoArray SNP Data
Study
phs003041
-
Cohort A RNA sequencing
Study
EGAS50000000950